Medtech

TAICEND's Patented Fish Collagen Technology Brings Breakthrough in the Healing of Hard-to-Heal Wounds

The formulation preserves the triple-helix structure of fish collagen, creating a stable biological scaffold that enhances cellular support throughout the healing process...

BioProtect Reports 4-Year Follow-Up Results Showing Lasting Quality-of-Life Gains

The newly presented data from the 164-patient cohort, confirm that these anatomic and dosimetric advantages translate into clinically meaningful, sustained preservation of quality of life...

Olympus Unveils Corporate Strategy

Shaping the future of endoscopy-enabled care through innovation and operational excellence...

Outset Medical Unveils Landmark Data on Dialysis Innovation at ASN Kidney Week 2025

Data from over 1 million Tablo treatments among the findings presented at the American Society of Nephrology’s Kidney Week 2025...

Femasys Secures FDA Approval to Advance Final FemBloc Trial Phase and $12Mn Financing

Successful completion of the first trial phase enables continued pivotal trial of FemBloc, the only non-surgical permanent birth control, toward U.S. FDA approval...

Apollo Cradle & Fertility unveils 3rd National Cradle Conference 2025

Apollo Cradle & Children’ Hospital along with Apollo Fertility launches the 3rd National Cradle Conference 2025, highlighting breakthrough technologies and best practices in fertility, maternal and child health...

Avance Clinical Showcases Early Phase Expertise and the Australian Advantage for EU Biotechs at BIO-Europe Vienna

Helping European Biotechs Accelerate Early Phase Success With Faster Timelines, Lower Costs, and Globally Accepted Data...

Strengthening Global Collaboration to Build Resilient, Sustainable Vaccine Ecosystem

The forum discusses strategies to strengthen vaccine production capacity, accelerate technology transfer, and expand access to safe, high-quality, and affordable vaccines for all...

HighTide’s HTD1801 Shows Long-Term Benefits for Type 2 Diabetes in Phase III Studies

The 52-week data from these two Phase III clinical trials demonstrate the durability of response and highlight the comprehensive long-term clinical benefits of HTD1801 in patients with T2DM...

Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights to VIS-101

This collaboration marks Everest’s strategic expansion into ophthalmology, a high-potential “blue-ocean” therapeutic area...